Allosteric Targeting of the Dopamine D2 Receptor: A novel Approach for the Treatment of Parkinson's Disease

  • Lane, Robert, (Primary Chief Investigator (PCI))
  • Capuano, Ben (Chief Investigator (CI))
  • Javitch, Jonathan (Chief Investigator (CI))
  • Shi, Lei (Chief Investigator (CI))
  • van den Buuse, Maarten (Chief Investigator (CI))

Project: Research

StatusFinished
Effective start/end date1/01/1631/12/18

Funding

  • National Health & Medical Research Council (NHMRC): AUD234,822.00
  • National Health & Medical Research Council (NHMRC): AUD234,822.00